3 transcripts
STVN
Earnings call transcript
NYSE
2024 Q2
6 Aug 24
in our innovative market-leading technologies. With the actions we have ongoing, we believe that we can drive the necessary improvements to bring
STVN
Earnings call transcript
NYSE
2024 Q1
9 May 24
such as aging populations with more complex health conditions; pharma innovation, particularly in sensitive biologics; and the trend towards the self
STVN
Earnings call transcript
NYSE
2023 Q4
7 Mar 24
.
It's a very, very good point because if we refer to our innovation, our products, one of our main innovation in the easy fill in the sterile market for cartage
- Prev
- 1
- Next